Science&Humans
PrivateLast Round
Series A
Jan 21, 2026
Total Funding Raised
$16.91M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Science&Humans is a healthtech company that operates a telemedicine platform offering personalized treatment for hormone health imbalances.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, D2C Brands, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Science&Humans Comparables
Compare Science&Humans with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phoenix | 83% | |
| Felix Health Inc. | 83% | |
| Jack Health | 78% |
Science&Humans Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 21, 2026 | ||||
| Debt | Dec 1, 2025 | ||||
| Series A | Dec 1, 2025 |
Science&Humans Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BDC Capital | Debt |
| CIBC Innovation Banking | Debt, Series A |
| WELL Ventures | Series A |
| Pender Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 206% MoM, reaching 58.5K.
- Jan 1, 2026
Michele Romanow named brand ambassador for 2026.
Recent news
Latest coverage and updates
- receives_financingJul 6, 2026
Science & Humans received financing of $7.1M on Jan 1st '26.
- launchesJun 16, 2026
Scienceandhumans launched Healthspan by Science&Humans on Jun 16th '26.
Science&Humans Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Science&Humans's valuation, stock price, and market status.
Is Science&Humans a public or private company?
Science&Humans is a private company.
What is the current stock price of Science&Humans?
Science&Humans is a private company with no public stock price. No recent secondary market data is available.
How much is Science&Humans worth (valuation)?
Valuation information for Science&Humans is not publicly available.
Can I buy Science&Humans stock?
Science&Humans shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Science&Humans's last funding round?
Science&Humans's most recent funding round was Series A on January 21, 2026.
Who are the main investors in Science&Humans?
Key investors in Science&Humans include Pender Ventures.
Will Science&Humans IPO soon?
No public IPO plans have been announced for Science&Humans.
How can I track Science&Humans secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Science&Humans's secondary market activity and sign up for updates.